Maintenance of the PCT national phase and EP validation for the patent “combined medicinal product” (Q3929399): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed an Item: Fixing rounding issue)
(‎Changed label, description and/or aliases in nl: Adding Dutch translations)
label / nllabel / nl
 
Handhaving van de nationale PCT-fase en EP-validering voor het octrooi „gecombineerd geneesmiddel”

Revision as of 11:08, 16 December 2021

Project Q3929399 in Hungary
Language Label Description Also known as
English
Maintenance of the PCT national phase and EP validation for the patent “combined medicinal product”
Project Q3929399 in Hungary

    Statements

    contained in NUTS
    Baranya
    0 references
    country
    Hungary
    0 references
    EU contribution
    3,407,120 forint
    0 references
    9,421.40 Euro
    exchange rate to Euro
    0.00276521 Euro
    point in time
    3 December 2021
    0 references
    budget
    9,313.79 Euro
    exchange rate to Euro
    0.0027336256 Euro
    point in time
    15 December 2021
    0 references
    3,407,120.0 forint
    0 references
    co-financing rate
    100.0 percent
    0 references
    start time
    25 July 2015
    0 references
    end time
    29 June 2017
    0 references
    beneficiary name (string)
    PÉCSI TUDOMÁNYEGYETEM
    0 references
    beneficiary
    Q3959590
    0 references
    coordinate location

    46°4'35.72"N, 18°13'40.94"E
    0 references
    location (string)
    Pécs, Baranya
    0 references

    Identifiers

    Hungarian Kohesio ID
    GINOP-2.1.3-15-2015-00029
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q3929399&oldid=19855512"